Why CEO AstraZeneca believes the drugmaker can almost double revenue by 2030

AstraZeneca CEO Pascal Soriot discussed his company's ambitious revenue goal with CNBC's Jim Cramer.

Jun 5, 2024 - 17:00
 0  2
Why CEO AstraZeneca believes the drugmaker can almost double revenue by 2030
AstraZeneca CEO Pascal Soriot discussed his company's ambitious revenue goal with CNBC's Jim Cramer.